X-83508573-C-A
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000307.5(POU3F4):c.249C>A(p.Pro83=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000224 in 1,205,081 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., 4 hem., cov: 24)
Exomes 𝑓: 0.000010 ( 0 hom. 2 hem. )
Consequence
POU3F4
NM_000307.5 synonymous
NM_000307.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.65
Genes affected
POU3F4 (HGNC:9217): (POU class 3 homeobox 4) This gene encodes a member of the POU-III class of neural transcription factors. This family member plays a role in inner ear development. The protein is thought to be involved in the mediation of epigenetic signals which induce striatal neuron-precursor differentiation. Mutations in this gene are associated with X chromosome-linked nonsyndromic mixed deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
?
Variant X-83508573-C-A is Benign according to our data. Variant chrX-83508573-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 1120056.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
?
Synonymous conserved (PhyloP=-2.65 with no splicing effect.
BS2
?
High Hemizygotes in GnomAd at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POU3F4 | NM_000307.5 | c.249C>A | p.Pro83= | synonymous_variant | 1/1 | ENST00000644024.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POU3F4 | ENST00000644024.2 | c.249C>A | p.Pro83= | synonymous_variant | 1/1 | NM_000307.5 | P1 | ||
ENST00000625081.1 | n.642G>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes ? AF: 0.000142 AC: 16AN: 112451Hom.: 0 Cov.: 24 AF XY: 0.000116 AC XY: 4AN XY: 34613
GnomAD3 genomes
?
AF:
AC:
16
AN:
112451
Hom.:
Cov.:
24
AF XY:
AC XY:
4
AN XY:
34613
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000304 AC: 5AN: 164308Hom.: 0 AF XY: 0.0000375 AC XY: 2AN XY: 53290
GnomAD3 exomes
AF:
AC:
5
AN:
164308
Hom.:
AF XY:
AC XY:
2
AN XY:
53290
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000101 AC: 11AN: 1092630Hom.: 0 Cov.: 31 AF XY: 0.00000557 AC XY: 2AN XY: 358956
GnomAD4 exome
AF:
AC:
11
AN:
1092630
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
358956
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000142 AC: 16AN: 112451Hom.: 0 Cov.: 24 AF XY: 0.000116 AC XY: 4AN XY: 34613
GnomAD4 genome
?
AF:
AC:
16
AN:
112451
Hom.:
Cov.:
24
AF XY:
AC XY:
4
AN XY:
34613
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Pro83Pro in Exon 01 of POU3F4: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 1/3204 African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 06, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at